Organization profile

Organization profile

The Center for Drug Design (CDD) is a distinctive, cutting edge research facility in the Academic Health Center of the University of Minnesota. We are dedicated to: Providing a research environment for leading scientists, Sharing unique strategies within the scientific community, Developing novel drug therapies, Vigorously pursuing an academic research agenda, Transferring scientific knowledge, Designing and developing new medicines to benefit people worldwide, Supporting the interaction of many disciplines and areas of study, and Creating a focal point for research.

Fingerprint Dive into the research topics where Center for Drug Design is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Nucleosides Medicine & Life Sciences
carbovir Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Organophosphonates Medicine & Life Sciences
NAD Medicine & Life Sciences
Inosine Monophosphate Medicine & Life Sciences
Derivatives Chemical Compounds
Ribonuclease H Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


No photo of Laurent Bonnac

Laurent Bonnac

Person: Research Faculty

No photo of Liqiang Chen

Liqiang Chen

Person: Faculty

No photo of Christine D Dreis

Christine D Dreis

Person: Researcher


Projects 2005 2024

Equipment and Supplies
Pharmaceutical Preparations
Alzheimer disease type 1

Research Output 1965 2019

1 Citation (Scopus)

5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors

Tang, J., Huber, A. D., Pineda, D. L., Boschert, K. N., Wolf, J. J., Kankanala, J., Xie, J., Sarafianos, S. G. & Wang, Z., Feb 15 2019, In : European Journal of Medicinal Chemistry. 164, p. 179-192 14 p.

Research output: Contribution to journalArticle

Virus Assembly
Hepatitis B virus
Viral Core Proteins

Challenges and Opportunities in Hepatitis B Research

Wang, Z., May 10 2019, In : ACS Infectious Diseases. 5, 5, p. 652-654 3 p.

Research output: Contribution to journalEditorial

Hepatitis B

Determinants of active-site inhibitor interaction with HIV-1 RNase H

Xi, Z., Wang, Z., Sarafianos, S. G., Myshakina, N. S. & Ishima, R., Jan 1 2019, (Accepted/In press) In : ACS Infectious Diseases.

Research output: Contribution to journalArticle

Ribonuclease H
Catalytic Domain
Antiviral Agents